Assessment of Safety, Tolerability, and Pharmacodynamic Effects of LY2886721 in Patients with Mild Cognitive Impairment Due to Alzheimer#s Disease or Mild Alzheimer's Disease

Grants and Contracts Details

StatusFinished
Effective start/end date11/1/124/24/14

Funding

  • Quintiles Inc: $56,501.00